Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Jim Cramer on Aquestive Therapeutics: “I Think It's a Very Interesting Spec” [Yahoo! Finance]
Looking at the Narrative for Aquestive Therapeutics After Patent Wins and FDA Milestones [Yahoo! Finance]
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.10 [Yahoo! Finance]
Aquestive Therapeutics (NASDAQ:AQST) had its price target raised by analysts at Piper Sandler from $5.00 to $8.00. They now have an "overweight" rating on the stock.